Skip to main content
OpenTrials

Clinical trial condition

Stage IV Uterine Corpus Leiomyosarcoma AJCC v8

Explore clinical trials studying Stage IV Uterine Corpus Leiomyosarcoma AJCC v8. Study availability and eligibility vary by location and protocol.

3 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Stage IV Uterine Corpus Leiomyosarcoma AJCC v8 trial results

Active, Not Recruiting

A Phase II Clinical Trial Evaluating the Combination of Olaparib and Temozolomide for the Treatment of Advanced Uterine Leiomyosarcoma

NCT03880019

Conditions
Stage III Uterine Corpus Leiomyosarcoma AJCC v8, Stage IV Uterine Corpus Leiomyosarcoma AJCC v8, Uterine Corpus Leiomyosarcoma
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • UCHealth University of Colorado Hospital Aurora, Colorado, United States
  • UF Health Cancer Institute - Gainesville Gainesville, Florida, United States
View all 15 locations
View Trial Details
Active, Not Recruiting

Testing Olaparib and Temozolomide Versus the Usual Treatment for Uterine Leiomyosarcoma After Chemotherapy Has Stopped Working

NCT05432791

Conditions
Locally Advanced Uterine Corpus Leiomyosarcoma, Metastatic Uterine Corpus Leiomyosarcoma, Stage III Uterine Corpus Leiomyosarcoma AJCC v8, +2 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
View all 145 locations
View Trial Details
Active, Not Recruiting

Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma

NCT04200443

Conditions
Leiomyosarcoma, Metastatic Leiomyosarcoma, Metastatic Soft Tissue Sarcoma, +14 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Northwestern University Chicago, Illinois, United States
  • University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details

Related conditions